4//SEC Filing
Entia Biosciences, Inc. 4
Accession 0001185185-16-005908
CIK 0001408299operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 9:57 PM ET
Size
7.9 KB
Accession
0001185185-16-005908
Insider Transaction Report
Form 4
HAUSMAN MARVIN S MD
DirectorCEO10% Owner
Transactions
- Purchase
Warrant
2016-12-05+40,000→ 40,000 totalExercise: $0.10From: 2016-12-05Exp: 2021-12-05→ Common Stock (40,000 underlying) - Purchase
10% Convertible
2016-12-05$10000.00/shFrom: 2016-12-05Exp: 2017-12-05→ Common Stock
Footnotes (2)
- [F1]Holder has option of repayment or conversation into securities of the subject company's next financing. Terms and underlying securities of next financing, if and when such financing occurs, have yet to be determined.
- [F2]As part of Unit.
Documents
Issuer
Entia Biosciences, Inc.
CIK 0001408299
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001408299
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 9:57 PM ET
- Size
- 7.9 KB